 FDx Advisors Inc. acquired a new position in shares of Momenta Pharmaceuticals, Inc. NASDAQ:MNTA during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 30,065 shares of the biotechnology companys stock, valued at approximately 37,000. A number of other institutional investors have also ... 